These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26831096)

  • 1. Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus.
    Sajda T; Hazelton J; Patel M; Seiffert-Sinha K; Steinman L; Robinson W; Haab BB; Sinha AA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1859-64. PubMed ID: 26831096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    Bhatia SM; Streilein RD; Hall RP
    PLoS One; 2020; 15(6):e0233957. PubMed ID: 32555697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity.
    Seiffert-Sinha K; Khan S; Attwood K; Gerlach JA; Sinha AA
    Front Immunol; 2018; 9():625. PubMed ID: 29675021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.
    Naseer SY; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association.
    Shah AA; Dey-Rao R; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2016 Jun; 49(4):248-57. PubMed ID: 26911801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the "Super Compensation Hypothesis".
    Sinha AA; Sajda T
    Front Med (Lausanne); 2018; 5():218. PubMed ID: 30155465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris.
    Di Lullo G; Calabresi V; Mariotti F; Zambruno G; Lanzavecchia A; Di Zenzo G
    Front Immunol; 2019; 10():1391. PubMed ID: 31275324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
    Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
    J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemphigus vulgaris autoantibody profiling by proteomic technique.
    Kalantari-Dehaghi M; Anhalt GJ; Camilleri MJ; Chernyavsky AI; Chun S; Felgner PL; Jasinskas A; Leiferman KM; Liang L; Marchenko S; Nakajima-Sasaki R; Pittelkow MR; Zone JJ; Grando SA
    PLoS One; 2013; 8(3):e57587. PubMed ID: 23505434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus.
    Loiseau P; Lecleach L; Prost C; Lepage V; Busson M; Bastuji-Garin S; Roujeau JC; Charron D
    J Autoimmun; 2000 Aug; 15(1):67-73. PubMed ID: 10936030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoglein autoimmunity in the pathogenesis of pemphigus.
    Gniadecki R
    Autoimmunity; 2006 Nov; 39(7):541-7. PubMed ID: 17101497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
    Kwon EJ; Yamagami J; Nishikawa T; Amagai M
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1070-5. PubMed ID: 18410336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
    Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
    Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.